FDA Signs Off on First At-Home Coronavirus Test

The Food and Drug Administration (FDA) on Tuesday issued an emergency use authorization for the first COVID-19 diagnostic at-home test. The move will not have an immediate impact on in-home care providers, but it could give them one more tool in their pandemic toolbox in weeks to come. The FDA specifically signed off on the […]

Current Health CEO: Readmissions, PDGM to Drive Expansion of Remote Patient Monitoring Tech

Current Health — makers of an artificial intelligence-powered wearable remote patient monitoring platform — cleared a major regulatory hurdle last month in securing FDA approval. The U.K.-based technology startup now has its sights set on expanding throughout the U.S. market, largely by helping home health agencies adapt to the Patient-Driven Groupings Model (PDGM) and by […]

Editor’s Picks: Regulations, Rules and Rising Rates

As 2016 starts winding down and the health care industry braces for changes likely to come with the incoming Trump administration, a few last-ditch laws are coming down the pike. We were sure to let our readers know which regulations could impact the home health and hospice industry, for better or for worse. We also […]

FDA Approves 2 Philips Telehealth Apps Aimed at Improving Transition Home

The Food and Drug Administration (FDA) has approved two telehealth apps from electronics company Philips that seek to ease the transition from hospital to home care, the company announced earlier this month.  The eCareCoordinator and eCareCompanion apps, part of Philips Hospital to Home’s suite of telehealth programs, focus on reducing readmissions to the hospital by providing […]

FDA Will Regulate Only Some Mobile Health Apps

The Food and Drug Administration (FDA) said last week that it would only regulate some of the growing numbers of mobile health apps, focusing specifically on those that could pose greater risks to patients. The agency intends to “exercise enforcement discretion,” according to a release, meaning it will not enforce requirements under the Federal Drug […]